We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$4.73B
AUM Growth
+$232M
Cap. Flow
-$76M
Cap. Flow %
-1.6%
Top 10 Hldgs %
17.46%
Holding
1,668
New
59
Increased
597
Reduced
846
Closed
63

Sector Composition

Rank Sector Weight
1 Technology 15.75%
2 Financials 14.08%
3 Healthcare 12.26%
4 Industrials 8.83%
5 Consumer Discretionary 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLY icon
151
Ally Financial
ALLY
$13.3B
$8.2M 0.17%
268,440
-19,493
-7% -$609K
XLI icon
152
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
$8.16M 0.17%
100,185
+934
+0.9% +$74.6K
CHRW icon
153
C.H. Robinson
CHRW
$17.3B
$8.09M 0.17%
103,462
+49,088
+90% +$3.91M
WST icon
154
West Pharmaceutical
WST
$24.9B
$7.88M 0.17%
52,394
+861
+2% +$125K
NBL
155
DELISTED
Noble Energy, Inc.
NBL
$7.86M 0.17%
316,203
-38,005
-11% -$807K
CNI icon
156
Canadian National Railway
CNI
$76.4B
$7.84M 0.17%
86,695
-505
-0.6% -$45.4K
RBA icon
157
RB Global
RBA
$17.7B
$7.78M 0.16%
181,080
+114
+0.1% +$4.75K
CHKP icon
158
Check Point Software Technologies
CHKP
$12.9B
$7.7M 0.16%
69,409
-5,721
-8% -$643K
GLOB icon
159
Globant
GLOB
$1.61B
$7.66M 0.16%
72,215
+347
+0.5% +$34.5K
BKR icon
160
Baker Hughes
BKR
$62B
$7.63M 0.16%
297,708
-11,587
-4% -$263K
EW icon
161
Edwards Lifesciences
EW
$51.7B
$7.59M 0.16%
97,629
-4,077
-4% -$318K
MS icon
162
Morgan Stanley
MS
$338B
$7.53M 0.16%
147,299
+3,250
+2% +$154K
ECL icon
163
Ecolab
ECL
$80.3B
$7.51M 0.16%
38,935
+1,732
+5% +$329K
VRTX icon
164
Vertex Pharmaceuticals
VRTX
$124B
$7.42M 0.16%
33,888
-3,185
-9% -$645K
TXN icon
165
Texas Instruments
TXN
$259B
$7.34M 0.16%
57,222
+845
+1% +$104K
CNC icon
166
Centene
CNC
$32.6B
$7.33M 0.15%
116,568
+8,444
+8% +$458K
RWO icon
167
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
$7.31M 0.15%
141,962
+1,143
+0.8% +$59.5K
SYK icon
168
Stryker
SYK
$130B
$7.31M 0.15%
34,828
+34
+0.1% +$7.06K
MSM icon
169
MSC Industrial Direct
MSM
$6.92B
$7.26M 0.15%
92,471
-33,197
-26% -$2.45M
INFO
170
DELISTED
IHS Markit Ltd. Common Shares
INFO
$7.06M 0.15%
93,708
-38,491
-29% -$2.74M
MAS icon
171
Masco
MAS
$15.2B
$7.06M 0.15%
147,068
+32,391
+28% +$1.47M
OMC icon
172
Omnicom Group
OMC
$23.2B
$6.98M 0.15%
86,125
+481
+0.6% +$37.7K
PRLB icon
173
Protolabs
PRLB
$2.12B
$6.95M 0.15%
68,437
-2,692
-4% -$267K
CHL
174
DELISTED
China Mobile Limited
CHL
$6.92M 0.15%
163,794
-15,688
-9% -$633K
VFH icon
175
Vanguard Financials ETF
VFH
$13.7B
$6.86M 0.14%
89,950
+539
+0.6% +$39.3K

Similar funds

Oppenheimer Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Oppenheimer Asset Management held 1,668 positions worth $4.73B, up 5.2% from $4.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer Asset Management's Q4 2019 filing shows 59 new, 597 increased, 846 reduced and 63 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 178,478 shares worth $9.59M. The largest sale was SunTrust Banks, Inc., an estimated $19.1M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer Asset Management's largest Q4 2019 buy was Vanguard FTSE All-World ex-US ETF: 178,478 shares worth $9.59M.
  • Oppenheimer Asset Management added most to Vanguard Morningstar Total Stock Market ETF in Q4 2019, an estimated $9.54M increase.
  • Oppenheimer Asset Management's biggest Q4 2019 reduction was SPX Corp, cutting an estimated $12.1M.
  • Oppenheimer Asset Management fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $19.1M.
  • Oppenheimer Asset Management's ten largest holdings make up 17% of its $4.73B portfolio in Q4 2019.
  • Oppenheimer Asset Management opened 59 new positions and closed 63 in Q4 2019.
  • Oppenheimer Asset Management's portfolio value rose 5.2% quarter-over-quarter to $4.73B.

Based on Oppenheimer Asset Management's 13F filing for Q4 2019, filed 7 Feb 2020.